Cancer Immunotherapy Month | Pancreatic Cancer Demystified: Expert Insights and Breakthroughs

Why is pancreatic cancer so difficult to diagnose? What treatment options are available against such a deadly foe? Join us for this exclusive webinar featuring renowned cancer immunologist, Dr. Robert H. Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.